• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.复发或难治性伯基特淋巴瘤和高级别B细胞白血病/淋巴瘤成人患者的治疗结果。
Am J Hematol. 2017 Jun;92(6):E114-E117. doi: 10.1002/ajh.24720. Epub 2017 Apr 18.
2
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.艾滋病相关伯基特淋巴瘤的临床结果：日本多机构回顾性调查。
Jpn J Clin Oncol. 2014 Apr;44(4):318-23. doi: 10.1093/jjco/hyu012. Epub 2014 Feb 20.
3
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.利妥昔单抗联合化疗治疗中枢神经系统和/或骨髓阳性的儿童及青少年伯基特淋巴瘤/白血病：儿童肿瘤学组报告
Br J Haematol. 2014 Nov;167(3):394-401. doi: 10.1111/bjh.13040. Epub 2014 Jul 26.
4
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.儿童非霍奇金淋巴瘤无中枢神经系统受累时的高生存率：科威特BFM 95研究结果
Pediatr Hematol Oncol. 2003 Mar;20(2):103-10. doi: 10.1080/0880010390158603.
5
Case report and review of immunodeficiency-associated Burkitt lymphoma.免疫缺陷相关伯基特淋巴瘤的病例报告及文献综述
Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e121-5. doi: 10.1016/j.clml.2014.12.010. Epub 2015 Jan 9.
6
[Therapeutic management of central nervous system lymphomas in a single hematological institute].[单一血液学机构中中枢神经系统淋巴瘤的治疗管理]
Orv Hetil. 2009 Oct 18;150(42):1937-44. doi: 10.1556/OH.2009.28703.
7
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.在日本成人弥漫性大 B 细胞淋巴瘤和伯基特淋巴瘤（BL）之间具有特征的不可分类的 B 细胞淋巴瘤患者中，采用或不采用利妥昔单抗的改良环磷酰胺、长春新碱、多柔比星和甲氨蝶呤（CODOX-M）/异环磷酰胺、依托泊苷和阿糖胞苷（IVAC）治疗。
Int J Hematol. 2010 Dec;92(5):732-43. doi: 10.1007/s12185-010-0728-0. Epub 2010 Dec 1.
8
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.儿童和青少年复发性霍奇金淋巴瘤的治疗结果——英国 HD3 复发治疗策略的结果。
Br J Haematol. 2014 May;165(4):534-44. doi: 10.1111/bjh.12768. Epub 2014 Feb 7.
9
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.异环磷酰胺、依托泊苷、阿糖胞苷和地塞米松作为挽救治疗，随后进行大剂量环磷酰胺、美法仑和依托泊苷联合自体外周血干细胞移植用于复发或难治性淋巴瘤。
Eur J Haematol. 2007 Feb;78(2):93-101. doi: 10.1111/j.1600-0609.2006.00796.x.
10
[Treatment outcome in primary testicular non-Hodgkin lymphoma].[原发性睾丸非霍奇金淋巴瘤的治疗结果]
Orv Hetil. 2013 Oct 20;154(42):1666-73. doi: 10.1556/OH.2013.29726.

引用本文的文献

1
Inhibiting the RNA helicase DDX3X in Burkitt lymphoma induces oxydative stress and impedes tumor progression in xenografts.抑制伯基特淋巴瘤中的RNA解旋酶DDX3X可诱导氧化应激并阻碍异种移植瘤的肿瘤进展。
Front Cell Dev Biol. 2025 Jul 23;13:1642006. doi: 10.3389/fcell.2025.1642006. eCollection 2025.
2
CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies.CD38嵌合抗原受体（CAR）人自然杀伤（NK）细胞与全反式维甲酸（ATRA）联合使用可增强对表达CD38的血液系统恶性肿瘤的细胞毒性。
Blood Neoplasia. 2024 Jul 31;1(4):100032. doi: 10.1016/j.bneo.2024.100032. eCollection 2024 Dec.
3
Phosphatidylinositol 3-Kinase Inhibition and Allogeneic Stem Cell Transplantation Can Overcome Chemotherapy Resistance in Refractory Burkitt Lymphoma.磷脂酰肌醇3激酶抑制与异基因干细胞移植可克服难治性伯基特淋巴瘤的化疗耐药性。
J Hematol. 2025 Mar;14(2):94-99. doi: 10.14740/jh2043. Epub 2025 Mar 18.
4
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.利妥昔单抗用于东非患有EBV阳性伯基特淋巴瘤的儿童。
Blood Adv. 2025 May 27;9(10):2393-2401. doi: 10.1182/bloodadvances.2024015234.
5
Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma.病例报告：一种新型第三代抗CD19/CD22嵌合抗原受体T细胞联合自体造血干细胞移植治疗复发性伯基特淋巴瘤。
Front Immunol. 2024 Dec 9;15:1497736. doi: 10.3389/fimmu.2024.1497736. eCollection 2024.
6
Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission.一名EBV阴性患者在完全缓解20年后出现伯基特淋巴瘤的极晚期复发。
Leuk Res Rep. 2024 Jul 29;22:100470. doi: 10.1016/j.lrr.2024.100470. eCollection 2024.
7
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies.难治性伯基特淋巴瘤：诊断与介入策略
Blood Lymphat Cancer. 2024 Mar 13;14:1-15. doi: 10.2147/BLCTT.S407804. eCollection 2024.
8
Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion.化疗耐药的伯基特淋巴瘤：包括嵌合抗原受体T细胞输注在内的可能的新型疗法。
Clin Case Rep. 2023 May 29;11(6):e7361. doi: 10.1002/ccr3.7361. eCollection 2023 Jun.
9
EBV and Lymphomagenesis.爱泼斯坦-巴尔病毒与淋巴瘤发生
Cancers (Basel). 2023 Apr 4;15(7):2133. doi: 10.3390/cancers15072133.
10
The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma.RNA解旋酶DDX3及其在c-MYC驱动的生发中心来源的B细胞淋巴瘤中的作用。
Front Oncol. 2023 Mar 24;13:1148936. doi: 10.3389/fonc.2023.1148936. eCollection 2023.

本文引用的文献

1
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.利妥昔单抗联合剂量密集化疗治疗成人伯基特淋巴瘤：一项随机、对照、开放标签、3 期临床试验。
Lancet. 2016 Jun 11;387(10036):2402-11. doi: 10.1016/S0140-6736(15)01317-3. Epub 2016 Apr 11.
2
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
3
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.在三项连续的前瞻性“Lymphomes Malins B”方案中接受治疗的成熟B细胞淋巴瘤和白血病儿童及青少年复发的结局及预后因素。法国儿童癌症协会的一项研究。
Haematologica. 2015 Jun;100(6):810-7. doi: 10.3324/haematol.2014.121434. Epub 2015 Feb 27.
4
How I treat Burkitt lymphoma in adults.成人伯基特淋巴瘤的治疗方法。
Blood. 2014 Nov 6;124(19):2913-20. doi: 10.1182/blood-2014-06-538504. Epub 2014 Sep 25.
5
Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents.儿童和青少年复发性或难治性伯基特淋巴瘤及成熟B细胞淋巴细胞白血病的临床结局
Cancer Res Treat. 2014 Oct;46(4):358-65. doi: 10.4143/crt.2013.047. Epub 2014 Jul 21.
6
Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.儿童复发或难治性成熟 B 细胞非霍奇金淋巴瘤和急性淋巴细胞白血病的结局。
Leuk Lymphoma. 2012 Oct;53(10):1882-8. doi: 10.3109/10428194.2012.677534. Epub 2012 Apr 23.
7
Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?伯基特淋巴瘤和非典型伯基特或伯基特样淋巴瘤：这些应该被视为不同的疾病吗？
Curr Hematol Malig Rep. 2011 Mar;6(1):58-66. doi: 10.1007/s11899-010-0076-4.
8
Burkitt's lymphoma: clinicopathologic features and differential diagnosis.伯基特淋巴瘤：临床病理特征与鉴别诊断
Oncologist. 2006 Apr;11(4):375-83. doi: 10.1634/theoncologist.11-4-375.
9
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.采用强化环磷酰胺、长春新碱、多柔比星及地塞米松（hyper-CVAD）联合利妥昔单抗进行化学免疫治疗，用于治疗成人伯基特淋巴瘤和伯基特样淋巴瘤或急性淋巴细胞白血病。
Cancer. 2006 Apr 1;106(7):1569-80. doi: 10.1002/cncr.21776.
10
Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation.成人伯基特氏和伯基特样非霍奇金淋巴瘤——首次缓解期或复发时接受大剂量治疗和自体干细胞移植患者的预后：欧洲血液与骨髓移植组的结果
J Clin Oncol. 1996 Sep;14(9):2465-72. doi: 10.1200/JCO.1996.14.9.2465.

Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.

作者信息

Short Nicholas J, Kantarjian Hagop M, Ko Heidi, Khoury Joseph D, Ravandi Farhad, Thomas Deborah A, Garcia-Manero Guillermo, Khouri Maria, Cortes Jorge E, Wierda William G, Verstovsek Srdan, Estrov Zeev, Ferrajoli Alessandra, Thompson Philip A, Pierce Sherry, O'Brien Susan M, Jabbour Elias

机构信息

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Am J Hematol. 2017 Jun;92(6):E114-E117. doi: 10.1002/ajh.24720. Epub 2017 Apr 18.

DOI:10.1002/ajh.24720
PMID:28295472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5828013/
Abstract
摘要